![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics to Present at the 2014 Wedbush Life Sciences Conference
August 07, 2014 09:15 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the company is scheduled to present at the Wedbush 2014 Life Sciences Conference on...
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics to Report Second Quarter 2014 Financial Results After Market on August, 7, 2014
August 04, 2014 09:15 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Aug. 4, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that it will report second quarter 2014 financial results after market close on Thursday,...
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics Announces EMA Acceptance for Review of Marketing Authorization Application for RAVICTI(R)
June 25, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., June 25, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the European Medicines Agency (EMA) has completed technical and content validation...
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics to Present at the JMP Healthcare Conference
June 18, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., June 18, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) today announced that the company is scheduled to present at the JMP Healthcare Conference on Tuesday, June 24,...
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics to Present at 2014 Wells Fargo Healthcare Conference
June 12, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., June 12, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) today announced that the company is scheduled to present at the 2014 Wells Fargo Healthcare Conference on...
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics Completes Acquisition of Andromeda Biotech, Ltd.
June 12, 2014 08:46 ET
|
Hyperion Therapeutics, Inc.
- Hyperion's Orphan Drug Pipeline Now Includes DiaPep277®, a First-in-Class Immunotherapy for New Onset Type 1 Diabetes, With Phase 3 Data Expected in the First Quarter of 2015...
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics Announces Health Canada Accepts RAVICTI(R) New Drug Submission With Priority Review
June 03, 2014 08:00 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., June 3, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the validation period is complete for its New Drug Submission (NDS) to Health Canada...
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics to Present at Jefferies 2014 Global Healthcare Conference
May 28, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., May 28, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) today announced that the company is scheduled to present at the Jefferies Global Healthcare Conference on...
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics to Present at Bank of America Merrill Lynch 2014 Health Care Conference
May 07, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., May 7, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) today announced that the company is scheduled to present at the Bank of America Merrill Lynch 2014 Health Care...
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics Announces First Quarter 2014 Financial Results
May 06, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
- Company signs definitive agreement to expand its pipeline -
- Company to Host Conference Call Today at 4:30 p.m. ET (1:30 p.m. PT) -
BRISBANE, Calif., May 6, 2014 (GLOBE NEWSWIRE) --...